Antabio's Grant - VII Round

Antabio raised a round of funding on July 25, 2017. Investors include CARB-X.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Grant - VII Round: